Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration.
Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration.
复制标题
澳大利亚国家癌症症状试验 (CST) 小组的研究人群与全国转诊至参与姑息治疗结果合作的非 CST 专科姑息治疗服务的可比性。
DOI：
10.1016/j.jpainsymman.2018.09.017
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Currow DC.
中科院分区：
文献类型：
--
作者：
Matsuoka H;Allingham S;Fazekas B;Brown L;Vandersman Z;Clark K;Agar MR;Currow DC.
结果902名癌症患者参加了17个地点的6项III期安慰剂对照、随机对照试验（表1）。在117个非CST研究中心观察到的75，240例癌症诊断患者的连续队列是对照人群。
ResultsNine hundred two people with cancer participated in six Phase III placebo-controlled, randomized controlled trials across 17 sites (Table 1). A consecutive cohort of 75,240 patients with a cancer diagnosis seen in 117 non-CST sites were the comparator population.